Tech Company Financing Transactions
NaZura BioHealth Funding Round
Morgenthaler Ventures joined a $86 thousand funding round for NaZura BioHealth. This venture round closed on 9/30/2013.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$86,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
11995 El Camino Real 305
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
NaZura BioHealth Inc. is focused on developing consumer and pharmaceutical products based on its proprietary Gut Sensory Modulation (GSM) technology. NaZura will be commercializing its lead product, LovidiaTM, a dietary supplement for weight management in the second half of 2014.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alain Baron
VP - Bus. Development
Mark Wiggins
VP - Finance
Martin Brown
VP - R & D
Mark Fineman
Browse more venture capital transactions:
Prev: 9/30/2013: Sneakpeeq venture capital transaction
Next: 9/30/2013: EyeGate Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs